L. Tadlock et T. Patel, Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line, HEPATOLOGY, 33(1), 2001, pp. 43-51
Although mitogen-activated protein kinase (MAPK) pathways play a key role i
n cell growth, their role in mediating the altered growth phenotype of tran
sformed cells remains unclear. The p44/p42 MAPK signaling cascades are acti
vated by mitogenic stimulation of human cholangiocytes. In contrast, the p3
8 MAPK pathway is activated by mitogen stimulation of malignant, but not no
nmalignant cholangiocytes, Thus, our aims were to determine the role of p38
MAPK signaling in mediating the growth phenotype of transformed cholangioc
ytes. KMCH-1 malignant human cholangiocytes required the presence of serum
for proliferation, but were able to grow in reduced serum conditions. Inhib
ition of p38 MAPK decreased serum-dependent proliferation of KMCH-1 cells,
Furthermore, inhibition of p38 MAPK, but not of p44/p42 MAPK, reduced ancho
rage-independent growth of KMCH-1 cells. Although both p38 and p44/p42 MAPK
are activated in response to mitogens, they have divergent effects on anch
orage-independent growth. Inhibition of p38 MAPK, but not of p44/p42 MAPK s
ignaling, decreased cell cycle progression and increased expression of the
cyclin-dependent kinase inhibitor p21(WAF1/CIP1) However, expression of p27
(KIP1) Or p16(INK4A) was not altered by either pathway. Thus, mitogen activ
ation of p38 MAPK decreases expression of p21(WAF1/CIP1) and mediates growt
h independent of anchorage signals, whereas mitogen activation of p44/p42 M
APK mediates an anchorage signal-dependent growth pathway. These data provi
de a link between aberrant stress-activated cell signaling and the altered
growth phenotype of transformed cells that may be important for the develop
ment of therapies to limit transformed cell growth.